Foghorn Therapeutics Inc.盘中异动股价大涨8.73%报4.61美元

市场透视2025-04-23

北京时间2025年04月23日21时35分，Foghorn Therapeutics Inc.（FHTX.us）股票出现异动，股价大幅拉升8.73%。截至发稿，该股报4.61美元/股，成交量1.0958万股，换手率0.02%，振幅5.51%。最近的财报数据显示，该股实现营业收入22.60百万美元，净利润-86.62百万美元，每股收益-1.58美元，毛利19.48百万美元，市盈率-2.92倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2529682226?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-23 21:35","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2529682226","market":"us","top_or_hot":-1,"title":"Foghorn Therapeutics Inc.盘中异动 股价大涨8.73%报4.61美元","media":"市场透视","content":"<div>\n<p>北京时间2025年04月23日21时35分，Foghorn Therapeutics Inc.（FHTX.us）股票出现异动，股价大幅拉升8.73%。截至发稿，该股报4.61美元/股，成交量1.0958万股，换手率0.02%，振幅5.51%。最近的财报数据显示，该股实现营业收入22.60百万美元，净利润-86.62百万美元，每股收益-1.58美元，毛利19.48百万美元，市盈率-2.92倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213544a6c53e41&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Foghorn Therapeutics Inc.盘中异动 股价大涨8.73%报4.61美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFoghorn Therapeutics Inc.盘中异动 股价大涨8.73%报4.61美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-23 21:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213544a6c53e41&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年04月23日21时35分，Foghorn Therapeutics Inc.（FHTX.us）股票出现异动，股价大幅拉升8.73%。截至发稿，该股报4.61美元/股，成交量1.0958万股，换手率0.02%，振幅5.51%。最近的财报数据显示，该股实现营业收入22.60百万美元，净利润-86.62百万美元，每股收益-1.58美元，毛利19.48百万美元，市盈率-2.92倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213544a6c53e41&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213544a6c53e41&s=b","article_id":"2529682226","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213544a6c53e41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2529682226","pubTimestamp":1745415344,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年04月23日21时35分，Foghorn Therapeutics Inc.股票出现异动，股价大幅拉升8.73%。截至发稿，该股报4.61美元/股，成交量1.0958万股，换手率0.02%，振幅5.51%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.99%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。该信息摘要如下：Foghorn Therapeutics获摩根大通证券公司首次覆盖，给予优于大市评级, 目标价9.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","FHTX":"Foghorn Therapeutics Inc.","BK4007":"制药","BK4139":"生物科技"},"translate_title":"Foghorn Therapeutics Inc. shares rose 8.73% to $4.61 after intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"FHTX":1},"content_text":"北京时间2025年04月23日21时35分，Foghorn Therapeutics Inc.（FHTX.us）股票出现异动，股价大幅拉升8.73%。截至发稿，该股报4.61美元/股，成交量1.0958万股，换手率0.02%，振幅5.51%。最近的财报数据显示，该股实现营业收入22.60百万美元，净利润-86.62百万美元，每股收益-1.58美元，毛利19.48百万美元，市盈率-2.92倍。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.99%。其相关个股中，Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025(To Pur Com)、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)涨幅较大，Ensysce Biosciences, Inc.、Onconetix, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为3365.69%、19.69%、11.18%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025(To Pur Com)、Silexion Therapeutics Corp，振幅分别为41.18%、29.61%、21.49%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。 其专有的基因流量控制平台对染色质调节系统的各个组成部分如何相互作用提供了一个综合的、机械的理解，使其能够识别、验证和潜在的系统内药物靶点。 该公司正在开发 FHD-286（一种选择性变构 ATP 酶抑制剂）和 FHD-609（一种蛋白质降解剂）， 用于治疗血液系统癌症和实体瘤。消息层面，截至21时35分，《Foghorn Therapeutics获摩根大通证券公司首次覆盖，给予优于大市评级, 目标价9.00美元。》资讯为影响Foghorn Therapeutics Inc.的重要信息。该信息摘要如下：Foghorn Therapeutics(FHTX.US)获摩根大通证券公司首次覆盖，给予优于大市评级, 目标价9.00美元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2529682226","isCrawlerRequest":true}

Foghorn Therapeutics Inc.盘中异动 股价大涨8.73%报4.61美元

精彩评论

Foghorn Therapeutics Inc.盘中异动股价大涨8.73%报4.61美元